Making Impressive Motion: Banco Santander, S.A. (NYSE:SAN), FS Bancorp (NASDAQ:FSBW), Seattle Genetics (NASDAQ:SGEN), Luxoft Holding (NYSE:LXFT)

Arlington Asset Investment Corp. (NYSE:AI) shares fell -2.63% in last trading session and ended the day at $11.83. AI has a return on assets of -2.80%. Arlington Asset Investment Corp. (NYSE:AI) quarterly performance is -15.14%.

On 2 February, Arlington Asset Investment Corp. (NYSE:AI) reported non-GAAP core operating income of $30.3 million for the quarter ended December 31, 2015, or $1.31 per diluted share. Excluding realized gains and losses on private-label mortgage-backed securities (“MBS”), the Company reported non-GAAP core operating income of $31.1 million, or $1.35 per diluted share. A reconciliation of non-GAAP core operating income measures to GAAP net income (loss) appears at the end of this press release.

Banco Santander, S.A. (NYSE:SAN) ended the last trading day at $4.12. Company weekly volatility is calculated as 3.47% and price to cash ratio as 0.29. Banco Santander, S.A. (NYSE:SAN) showed a weekly performance of -1.67%.

On 1 February, Banco Santander, S.A. (NYSE:SAN) announced its unaudited results for the Fourth quarter of 2015. Net income attributable to shareholders in 4Q15 totaled Ch$83,783 million (Ch$0.44 per share and US$0.25/ADR), decreasing 35.2% QoQ and 39.6% YoY.

On 05 February, FS Bancorp, Inc. (NASDAQ:FSBW) shares fell -1.98% and was closed at $23.81. FSBW EPS growth in last 5 year was 25.20%. FS Bancorp, Inc. (NASDAQ:FSBW) year to date (YTD) performance is -8.42%.

On 28 January, FS Bancorp, Inc. (NASDAQ:FSBW) reported 2015 net income of $8.9 million, or $2.93 per diluted share, compared to net income of $4.5 million or $1.52 per diluted share, for the same period last year. Net income for the fourth quarter of 2015 was $2.0 million, or $0.66 per diluted share, compared to $1.5 million, or $0.52 per diluted share, for the fourth quarter ended December 31, 2014.

Seattle Genetics, Inc. (NASDAQ:SGEN) shares fell -3.13% in last trading session and ended the day at $31.85. SGEN Gross Margin is 88.80% and its has a return on assets of -22.00%. Seattle Genetics, Inc. (NASDAQ:SGEN) quarterly performance is -28.07%.

Seattle Genetics, Inc. (NASDAQ:SGEN) announced that it will receive a one-time $20 million milestone payment under its ADCETRIS (brentuximab vedotin) collaboration with Takeda Pharmaceutical Company Limited (Takeda). The milestone was triggered by Takeda surpassing annual ADCETRIS net sales of $200 million in its territory during 2015.

Luxoft Holding, Inc. (NYSE:LXFT) caters to the Technology space. It has a net profit margin of 11.90% and weekly performance is -22.99%. On the last day of trading company shares ended up at $57.82. Luxoft Holding, Inc. (NYSE:LXFT) distance from 50-day simple moving average (SMA50) is -22.43%.

Luxoft Holding, Inc. (NYSE:LXFT) announced that Lincoln Popp, Managing Director of Luxoft North America, and Alina Plaia, Vice President and Investor Relations Officer, will be conducting one-on-one meetings at the Cantor Fitzgerald Internet & Technology Conference on 25 February.